MED Medifast Inc

Price (delayed)

$11.73

Market cap

$131.15M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.33

Enterprise value

$86.86M

?
Relative Growth: Rel. Growth: 0
Relative Strength: Rel. Strength: 60
Relative Valuation: Rel. Valuation: 44
Relative Profitability: Rel. Profitability: 25

® : Medifast is the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTA VIA®, which provides people with a simple, yet comprehensive approach to help ...

Highlights
The company's quick ratio rose by 16% YoY and by 2.3% QoQ
Medifast's debt has soared by 111% YoY and by 72% from the previous quarter
Medifast's gross profit has decreased by 38% YoY and by 10% from the previous quarter

Key stats

What are the main financial stats of MED

MED stock price

How has the Medifast stock price performed over time
Intraday
2.62%
1 week
-3.62%
1 month
-7.42%
1 year
-14.19%
YTD
9.83%
QTD
1.82%

Financial performance

How have Medifast's revenue and profit performed over time
Revenue
$316.93M
Gross profit
$219.45M
Operating income
-$19.51M
Net income
-$25.6M
Gross margin
69.2%
Net margin
-8.1%
Medifast's net margin has decreased by 40% from the previous quarter
Medifast's gross profit has decreased by 38% YoY and by 10% from the previous quarter
MED's revenue is down by 34% year-on-year and by 8% since the previous quarter
Medifast's operating margin has decreased by 32% QoQ

Price vs fundamentals

How does MED's price correlate with its fundamentals

Growth

What is Medifast's growth rate over time

Valuation

What is Medifast stock price valuation
P/E
N/A
P/B
0.66
P/S
0.41
EV/EBIT
N/A
EV/EBITDA
19.35
EV/Sales
0.27
The EPS has declined by 28% since the previous quarter
MED's P/B is 85% below its 5-year quarterly average of 4.3 but 10% above its last 4 quarters average of 0.6
The equity has contracted by 9% YoY
The P/S is 37% higher than the last 4 quarters average of 0.3 but 32% lower than the 5-year quarterly average of 0.6
MED's revenue is down by 34% year-on-year and by 8% since the previous quarter

Efficiency

How efficient is Medifast business performance
The return on sales has dropped by 91% since the previous quarter
The return on invested capital has dropped by 61% since the previous quarter
MED's ROE is down by 31% QoQ
The ROA has decreased by 30% from the previous quarter

Dividends

What is MED's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history

Special dividends are included in TTM DPS and yield

Financial health

How did Medifast financials performed over time
Medifast's total liabilities has increased by 20% YoY and by 18% QoQ
The company's quick ratio rose by 16% YoY and by 2.3% QoQ
Medifast's debt is 86% less than its equity
Medifast's debt to equity has soared by 133% YoY and by 75% from the previous quarter
Medifast's debt has soared by 111% YoY and by 72% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.